RNS Number : 4318X Renalytix PLC 05 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company
National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes ARLINGTON, Va. and SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The American Diabetes
RNS Number : 2538X Renalytix PLC 04 January 2022 Renalytix plc ("Renalytix" or the "Company") American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population National program establishes early care management, technology innovation and large
RNS Number : 0925W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Result of AGM LONDON and SALT LAKE , 17 December 2021 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were
RNS Number : 0593W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000
RNS Number : 3617V Renalytix PLC 13 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of
RNS Number : 1070V Renalytix PLC 09 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of
RNS Number : 9024U Renalytix PLC 08 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,
RNS Number : 7546U Renalytix PLC 07 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 LONDON and SALT LAKE CITY , December 7, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial
